Literature DB >> 10500897

Pulsatile hemodynamics in hypertension.

G F Mitchell1, M A Pfeffer.   

Abstract

The hemodynamics of hypertension and antihypertensive therapy have generally been approached in terms of the steady-flow load on the heart. Recent evidence, however, suggests that the pulsatile component of hemodynamic load may play a fundamental role in both the development and progression of hypertensive cardiovascular disease and its clinical sequelae. Pulse pressure, a correlate of conduit vessel stiffness, has been shown to be an important independent predictor of clinical events in hypertensive patients and in the general population. Unrecognized effects on pulsatile hemodynamics may account for the differential effects of various agents on left ventricular mass and events. A better understanding of abnormalities in pulsatile load in hypertension will facilitate risk stratification in and treatment of patients with hypertension.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10500897     DOI: 10.1097/00001573-199909000-00002

Source DB:  PubMed          Journal:  Curr Opin Cardiol        ISSN: 0268-4705            Impact factor:   2.161


  3 in total

Review 1.  Complex regulation and function of the inflammatory smooth muscle cell phenotype in atherosclerosis.

Authors:  Anthony Wayne Orr; Nicole E Hastings; Brett R Blackman; Brian R Wamhoff
Journal:  J Vasc Res       Date:  2009-10-22       Impact factor: 1.934

2.  Insights on atherosclerosis by non-invasive assessment of wall stress and arterial morphology along the length of human coronary plaques.

Authors:  Sotirios A Katranas; Antonios P Antoniadis; Anastasios L Kelekis; George D Giannoglou
Journal:  Int J Cardiovasc Imaging       Date:  2015-08-09       Impact factor: 2.357

3.  Surveillance of cardiovascular risk in the normotensive patient with repaired aortic coarctation.

Authors:  Lorna Swan; Mustafa Kraidly; Isabelle Vonder Muhll; Peter Collins; Michael A Gatzoulis
Journal:  Int J Cardiol       Date:  2008-12-06       Impact factor: 4.164

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.